Home A plea for intra-laboratory reference limits. Part 2. A bimodal retrospective concept for determining reference limits from intra-laboratory databases demonstrated by catalytic activity concentrations of enzymes
Article
Licensed
Unlicensed Requires Authentication

A plea for intra-laboratory reference limits. Part 2. A bimodal retrospective concept for determining reference limits from intra-laboratory databases demonstrated by catalytic activity concentrations of enzymes

  • Farhad Arzideh , Werner Wosniok , Eberhard Gurr , Wilhelm Hinsch , Gerhard Schumann , Nicodemo Weinstock and Rainer Haeckel
Published/Copyright: August 1, 2007
Become an author with De Gruyter Brill
Clinical Chemistry and Laboratory Medicine (CCLM)
From the journal Volume 45 Issue 8

Abstract

Background: The current recommendations for establishing intra-laboratory reference limits (RLs) cannot be fulfilled by most laboratories because of the expense involved. In the current study, a bimodal method was developed to derive RLs from data stored in a laboratory information system without any assumption concerning the distribution of the diseased subgroup.

Methods: A smoothed kernel density function (Dmix) was estimated for the distribution of combined data for non-diseased and diseased adult subjects. It was assumed that the “central” part of the distribution represents the non-diseased population, which was defined and used to estimate a Gaussian distribution of either the original values or Box-Cox transformed data. This normal distribution was now considered the distribution of the non-diseased subgroup (Dnd). Percentiles were calculated to obtain retrospective RLs. The density function of the diseased subgroup (Dd) was calculated by subtracting the non-diseased density function from Dmix (Dd=Dmix–Dnd). The intersection point of the Dnd and Dd curves identified the RL with the highest diagnostic efficiency.

Results: The model was applied to catalytic activity concentrations of several enzymes with data from different laboratories. The RLs obtained were similar to recently published consensus values. Differences between laboratories were small but significant. Gender stratification was necessary for alanine aminotransferase (ALT), aspartate aminotransferase (AST), and γ-glutymaltransferse (γ-GT), not significant for lipase and amylase and inconsistent among the laboratories for alkaline phosphatase (AP) and lactate dehydrogenase (LDH). Age stratification was only tested for two groups (18–49 and ≥50 years) and was significant for AST (females only), γ-GT and lipase, not significant for amylase and inconsistent for AP, LDH and ALT. For γ-GT, further stratification for age in decades was necessary for males. Creatine kinase MB (CK-MB) values were not stratified owing to the low number of data available.

Conclusions: Retrospective RLs derived from intra-laboratory data pools for the catalytic activity concentration of enzymes using a modified procedure plausibly agreed with published consensus values. However, most RLs varied significantly among laboratories, thus supporting the “old” plea for intra-laboratory RLs.

Clin Chem Lab Med 2007;45:1043–57.


Corresponding author: Prof. Dr. Rainer Haeckel, Diagnostic Center Wagner Stibbe, Werner-von-Siemens Str. 10, 37077 Göttingen, Germany Phone: +49-421-273446,

Received: 2007-1-2
Accepted: 2007-4-7
Published Online: 2007-08-01
Published in Print: 2007-08-01

©2007 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Congress of Clinical Chemistry and Laboratory Medicine, Joint Annual Congress of The Austrian Society for Laboratory Medicine and Clinical Chemistry (OEGLMKC) and the The German United Society of Clinical Chemistry and Laboratory Medicine (DGKL), Vienna, Austria, September 19-22, 2007
  2. Interpretation of laboratory results: the Reference Intervals, a necessary evil?
  3. Implementation of haemoglobin A1c results traceable to the IFCC reference system: the way forward
  4. Exhaled breath condensate: a new method for lung disease diagnosis
  5. Biochemical markers of alcoholism
  6. Polymorphisms of the peroxisome proliferator-activated receptor-γ coactivator-1α gene are associated with hypertrophic cardiomyopathy and not with hypertension hypertrophy
  7. Association of interleukin-1 genetic polymorphisms with the risk of rheumatoid arthritis in Chinese population
  8. Highest accuracy of combined consensus clinical criteria and SNRPN gene molecular markers in diagnosis of Prader-Willi syndrome in Thai patients
  9. Use of maternal plasma for non-invasive prenatal diagnosis of fetal ABO genotypes
  10. Relationship of the CAG repeat polymorphism of the MEF2A gene and coronary artery disease in a Chinese population
  11. Specific real-time PCR vs. fluorescent dyes for serum free DNA quantification
  12. Increased glycation of hemoglobin and plasma proteins in normotensive, non-diabetic obese Indian subjects: putative role of lipid peroxides
  13. The relationship between red blood cell and reticulocyte indices and serum markers of iron status in the cord blood of newborns
  14. Association of amino-terminal propeptide of type III procollagen and acute myocardial rejection in male patients receiving heart transplantation
  15. Changes in platelet count and indices in pulmonary tuberculosis
  16. Activity or mass concentration of bone-specific alkaline phosphatase as a marker of bone formation
  17. A simple isocratic HPLC assay to determine linezolid concentrations in different biomatrices for in vivo and in vitro studies
  18. Pitfalls in measuring the endocannabinoid 2-arachidonoyl glycerol in biological samples
  19. Partitioning reference values for several subpopulations using cluster analysis
  20. A plea for intra-laboratory reference limits. Part 1. General considerations and concepts for determination
  21. A plea for intra-laboratory reference limits. Part 2. A bimodal retrospective concept for determining reference limits from intra-laboratory databases demonstrated by catalytic activity concentrations of enzymes
  22. Biological variation of thyroid autoantibodies and thyroglobulin
  23. Monitoring glycaemic control: is there evidence for appropriate use of routine measurement of glycated haemoglobin?
  24. Performance and utility of a cost-effective collagen-binding assay for the laboratory diagnosis of Von Willebrand disease
  25. Hook effect in calcitonin immunoradiometric assay
  26. Rapid genotyping of the Ser447Stop variant of the lipoprotein lipase gene using real-time fluorescent PCR
  27. Global standardization of glycated hemoglobin measurement: the position of the IFCC Working Group
  28. Recommendation for term and measurement unit for “HbA1c”
  29. Desirable performance standards for HbA1c analysis – precision, accuracy and standardisation Consensus statement of the Australasian Association of Clinical Biochemists (AACB), the Australian Diabetes Society (ADS), the Royal College of Pathologists of Australasia (RCPA), Endocrine Society of Australia (ESA), and the Australian Diabetes Educators Association (ADEA)
  30. IFCC Position Paper: Report of the IFCC Taskforce on Ethics: Introduction and framework
  31. IFCC Awards: Call for Nominations
  32. Call for papers, ideas and initiatives
Downloaded on 3.12.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2007.250/html
Scroll to top button